Anti-inflammatory effects of fermented and non-fermented Sophora flavescens: a comparative study
© Han et al; licensee BioMed Central Ltd. 2011
Received: 21 July 2011
Accepted: 26 October 2011
Published: 26 October 2011
The roots of Sophora flavescens (Leguminosae) have been used in East Asian countries as an herbal medicine and a food ingredient for thousands of years. The aim of the present study was to investigate the effects of S. flavescens fermentation on endotoxin-induced uveitis (EIU) in rats.
EIU was induced in rats via a footpad injection of lipopolysaccharide (LPS). Immediately after the LPS inoculation, fermented and non-fermented extracts of S. flavescens (FSE and NFSE, respectively) were administered orally, and the aqueous humor was collected from both eyes 24 hours later. The anti-inflammatory effects of FSE and NFSE were examined in terms of regulation of nuclear factor kappa B (NF-κB) activation and the expression of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), inducible nitric oxide synthase (iNOS), intercellular cell adhesion molecule (ICAM)-1, and cyclooxygenase-2 (COX-2). The regulation of maleic dialdehyde (MDA) levels and polymorphonuclear cell (PMN) infiltration by FSE and NFSE were also examined.
Treatment with FSE significantly inhibited LPS-induced increases in IL-1β and TNF-α production and the expression of iNOS, ICAM-1 and COX-2. Moreover, FSE suppressed LPS-induced NF-κB activation, and reduced both MDA levels and infiltration by PMN.
These results indicate that solid state fermentation may enhance the anti-inflammatory effects of S. flavescens.
Inflammation plays an important role in a wide variety of chronic human diseases including cardiovascular diseases and cancer. Although various chemical regimens have been used to treat inflammation, efficacy can be unsatisfactory and may encounter the problem of drug resistance. To improve treatments based on anti-inflammatory chemicals, novel therapeutic strategies may be developed from medical plants used in Chinese Traditional Medicine. Of the huge array of candidates available, we chose to investigate Sophora flavescens (Leguminosae) because of its potential health promoting properties; it is anti-inflammatory, an anti-asthmatic, an anthelmintic, and a free radical scavenger, and it has antimicrobial activities and improves mental health [1–5].
The roots of S. flavescens (Leguminosae) have been traditionally used in East Asian countries as an herbal medicine and food ingredient for thousands of years. S. flavescens contains alkaloids, triterpenoids, and flavonoids, which are known to have various biological activities . However, different processing methods (such as fermentation) change the properties of this material. Therefore, the aim of the present study was to develop a solid state fermentation (SSF) protocol for S. flavescens and to investigate whether this method led to an increase in its anti-inflammatory effects.
SSF is a fermentation process conducted on a solid support, which has low moisture content and occurs in a non-septic and natural state . SSF is a cutting-edge, clean technology with great potential for use in the production or extraction of biologically active compounds from natural sources. Some studies show that SSF changes the properties of the plant materials; therefore, we compared the anti-inflammatory properties of fermented and non-fermented roots.
To better elucidate the anti-inflammatory effects of the fermented and non-fermented extracts of S. flavescens (FSE and NFSE, respectively), a rat model of endotoxin-induced uveitis (EIU) was created by inducing acute anterior segment intraocular inflammation via an injection of lipopolysaccharide (LPS) [8, 9]. In this model, LPS directly stimulates the vascular endothelium, macrophages, and other inflammatory cells, which release factors such as nitric oxide [10, 11], cytokines (including tumor necrosis factor (TNF-α)) , and eicosanoid mediators . The levels of these molecules were measured in FSE- or NFSE-treated rat eyes. The results showed that SSF enhances the anti-inflammatory effects of S. flavescens in a rat model of EIU.
The roots of S. flavescens were collected from Shandong Province, China, in October 2009. A fine powder for use in the extraction study was prepared by milling dry S. flavescens with a mechanical grinder and sieving through a 20-mesh metal sieve.
Microorganisms and fermentation
The seeds of Coprinus comatus were purchased from the Agricultural Culture Collection of China. First, the seeds were grown at 28°C for 5 days on PDA slants (1,000 mL 20% potato extract liquid + 20.0 g dextrose + 20.0 g agar) and then maintained at 4°C in a refrigerator. Five to six pieces of C. comatus mycelia were transferred from a slant into 250 mL Erlenmeyer flasks containing 100 mL liquid medium (20% potato extract liquid + 2.0% dextrose + 0.1% KH2PO4 + 0.05% MgSO2). The culture was incubated at 27°C on a rotary shaker at 180 rpm for 7 days [14, 15].
Ground S. flavescens (50 g) was autoclaved in Erlenmeyer flasks (500 mL) for 20 min at 121°C. After cooling, the flasks were inoculated with 15 mL of inoculum and incubated at 27°C for 30 days.
FSE and NFSE preparation
Fermented and non-fermented S. flavescens was dried at room temperature (24.2 ± 1.0°C), and refluxed and extracted three times for 4 h in boiling water at a dried material to solvent ratio of 1:6 (w/v). The supernatant was collected by filtration, and the solvent was evaporated under reduced pressure and lyophilized.
Healthy male adult Wistar rats (2 months old and weighing 225 ± 25 g) were used in the study. The study was approved by Shandong University's ethics committee, and all procedures complied with the guidance set out in the Guidelines for Caring for Experimental Animals published by the Ministry of Science and Technology of the People's Republic of China. Every care was taken to minimize discomfort, distress, and pain.
EIU was induced by a footpad injection of 200 μg LPS (from Escherichia coli, Nanjing Duly Biotech Co., Ltd., China; 100 μg per footpad) diluted in 0.1 mL phosphate-buffered saline (pH 7.4).
Thirty EIU rats were selected and divided three equal groups: an endotoxin-treated group, an FSE-treated group, and an NFSE-treated group. The three groups were given oral saline, FSE (75 mg/kg/d) or NFSE (75 mg/kg/d), respectively. Ten normal control rats were given saline only. Twenty-four hours later, the rats were sacrificed and the aqueous humor (15-20 μL/rat) was collected from both eyes for measurement of inflammatory cells and inflammatory mediators.
Measurement of maleic dialdehyde (MDA)
MDA, a reliable marker for lipid peroxidation, was measured using a thiobarbituric acid assay (Nanjing Jiancheng Bioengineering Institute) according to the manufacturer's instructions. The total protein content of the samples was measured using a Coomassie Blue assay (Nanjing Jiancheng Bioengineering Institute) and the MDA content (nmol/mg protein) calculated using the following formula: absorbance of sample tube/absorbance of standard tube × 2.5.
Measurement of PMN infiltration
Myeloperoxidase (MPO) activity was measured to assess the extent of polymorphonuclear cell (PMN) infiltration into the eyes using a commercial assay kit (Nanjing Jiancheng Bioengineering Co., Ltd., China).
Measurement of IL-1β and TNF-α
The concentration of interleukin-1β (IL-1β) and TNF-α in the aqueous humor was determined using a commercial ELISA kit (Shanghai Jinma Biological Technology Inc., China) according to the manufacturer's instructions.
Measurement of NF-κB activation
Nuclear factor kappa B (NF-κB) activation in the eyes was determined using an ELISA kit (Shanghai Jinma Biological Technology Inc., China) according to the manufacturer's instructions. This kit specifically detects the p50 sub-unit of NF-κB.
Measurement of ICAM-1, iNOS, and COX-2 levels
Expression of intercellular cell adhesion molecule (ICAM)-1, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) was examined using a commercially available immunohistochemistry kit (Hengdabaisheng Biotechnology, Beijing, China) according to the manufacturer's instructions.
Data were expressed as the mean ± S.E.M. and the results analyzed by ANOVA followed by Dunnett's t test. A p value of < 0.05 was considered significant.
Results and Discussion
S. flavescens has many pharmacological properties, including anti-inflammatory activity. Therefore, the aim of the present study was to investigate whether SSF enhanced the anti-inflammatory effects of S. flavescens.
During SSF, the microorganisms associated with fermentation degrade the plant cell walls, enabling the release of biologically active compounds during the next extraction stage. This results in high concentrations of biologically active compounds, which may enhance the anti-inflammatory effects of S. flavescens.
Effects of FSE and NFSE on MPO activity
0.99 ± 0.21*
2.08 ± 0.22
1.11 ± 0.15*
1.87 ± 0.20
Effects of FSE and NFSE on ICAM-1, iNOS, and COX-2 protein production (number of immunopositive cells/mm2)
22.22 ± 6.22**
10.41 ± 3.88**
9.06 ± 5.04**
135.11 ± 21.35
68.28 ± 9.30
71.22 ± 8.23
46.41 ± 1.23**
26.22 ± 1.39*
18.08 ± 3.22**
98.41 ± 33.31*
51.32 ± 2.59
50.11 ± 11.32*
Nitric oxide (NO) production, induced by bacterial LPS or cytokines, plays an important role in endotoxemia and inflammatory conditions , and selective inhibitors of iNOS inhibit the development of EIU . Therefore, we wondered whether FSE, which inhibits NO production by inhibiting iNOS expression, had any positive therapeutic effects on inflammation. The results showed that FSE treatment inhibited the development of EIU and suppressed LPS-induced iNOS expression. Treatment with NFSE also reduced iNOS expression; however, this was not statistically significant.
NO also activates COX enzymes leading to a marked increase in PGE2 production . COX-2 is primarily responsible for increased PGE2 production during inflammation, and PGE2 is generally considered to be a pro-inflammatory agent [25, 26]. As shown in Table 2, the expression of COX-2 in the EIU group was significantly increased compared with that in the control group. FSE and NFSE treatment significantly decreased the expression of COX-2 protein in EIU rats (p < 0.01 and p < 0.05, respectively).
The results of the present study clearly demonstrate the protective effects of FSE against EIU in rats. FSE treatment inhibited the production of EIU-induced inflammatory cytokines (IL-1β and TNF-α), decreased the levels of inflammation-related markers (MPO and ICAM-1), decreased the expression of pro-oxidative enzymes such as COX-2 and iNOS, and down-regulated the expression of NF-κB. Although both NFSE and FSE showed protective effects against EIU in rats, there was a significant difference between them. Taken together, the results of the present study show that SSF enhances the anti-inflammatory effects of S. flavescens.
List of abbreviations
fermented S. flavescens extract
non-fermented S. flavescens extract
nuclear factor kappa B
inducible nitric oxide synthase
tumor necrosis factor-α
intercellular cell adhesion molecule
solid state fermentation.
This study was supported by the Project of Shandong Province Higher Educational Science and Technology Program (J08LH62), NNSF grant (30800301, 31170992), the Key New Drugs Innovation project from Ministry of Science and Technology (2010ZX09102-201-018) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-254, KSCX2-EW-Q-18 and KSCX2-EW-J-8). This project was also supported by Natural Science Foundation of Shandong Province (Y2007C078).
- Yagi A, Fukunaga M, Okuzako N, Mifuchi I, Kawamoto F: Antifungal substances from Sophora flavescens. Shoyakugaku Zasshi. 1989, 43: 343-347.Google Scholar
- Kuroyanagi M, Arakawa T, Hirayama Y, Hayashi T: Antibacterial and antiandrogen flavonoids from Sophora flavescens. J Nat Prod. 1999, 62: 1595-1599. 10.1021/np990051d.View ArticlePubMedGoogle Scholar
- Kim DW, Chi YS, Son KH, Chang HW, Kim JS, Kang SS, Kim HP: Effects of sophoraflavanone G, a prenylated flavonoid from Sophora flavescenes, on cyclooxygenase-2 and in vitro inflammatory response. Arch Pharm Res. 2002, 25: 329-335. 10.1007/BF02976635.View ArticlePubMedGoogle Scholar
- Hwang JS, Lee SA, Hong SS, Lee KS, Lee MK, Hwang BY, Ro JS: Monoamine oxidase inhibitory components from the roots of Sophora flavescens. Arch Pharm Res. 2005, 28: 190-194. 10.1007/BF02977714.View ArticlePubMedGoogle Scholar
- Jung HJ, Kang SS, Hyun SK, Choi JS: In vitro free radical and ONOO- scavengers from Sophora flavescens. Arch Pharm Res. 2005, 28: 534-540. 10.1007/BF02977754.View ArticlePubMedGoogle Scholar
- Tang W, Eisenbrand G: "Chinese Drugs of Plant Origin". Springer, Heidelberg. 1992, 931-943.Google Scholar
- Nigam P: Process selection for protein enrichment; fermentation of the sugars industry by-products molasses and sugar beet pulp. Proc Biochem. 1994, 29: 337-342. 10.1016/0032-9592(94)87002-0.View ArticleGoogle Scholar
- Baatz H, Tonessen B, Prada J, Pleyer U: Thalidomide inhibits leukocyte-endothelium interaction in endotoxin-induced uveitis. Ophthalmic Res. 2001, 33: 256-263. 10.1159/000055678.View ArticlePubMedGoogle Scholar
- Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S: Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci. 2003, 44: 2694-2701. 10.1167/iovs.02-0822.View ArticlePubMedGoogle Scholar
- Shiratori K, Ohgami K, Ilieva IB, Koyama Y, Yoshida K, Ohno S: Inhibition of endotoxin-induced uveitis and potentiation of cyclo-oxygenase-2 protein expression by alpha-melanocyte-stimulating hormone. Invest Ophthalmol Vis Sci. 2004, 45: 159-164. 10.1167/iovs.03-0492.View ArticlePubMedGoogle Scholar
- Pearson W, Fletcher RS, Kott LS, Hurtig MB: Protection against LPS-induced cartilage inflammation and degradation provided by a biological extract of Mentha spicata. BMC Complement Altern Med. 2010, 10: 19-10.1186/1472-6882-10-19.View ArticlePubMedPubMed CentralGoogle Scholar
- Boujedaini N, Liu J, Thuillez C, Cazin L, Mensah-Nyagan AG: In vivo regulation of vasomotricity by nitric oxide and prostanoids during gestation. Eur J Pharmacol. 2001, 427: 143-149. 10.1016/S0014-2999(01)01233-X.View ArticlePubMedGoogle Scholar
- Tracey KJ, Cerami A: Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994, 45: 491-503. 10.1146/annurev.med.45.1.491.View ArticlePubMedGoogle Scholar
- Han C, Yuan J, Wang Y, Li L: Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol. 2006, 20: 191-196. 10.1016/j.jtemb.2006.06.003.View ArticlePubMedGoogle Scholar
- Han C, Cui B, Wang Y: Vanadium uptake by biomass of Coprinus comatus and their effect on hyperglycemic mice. Biol Trace Elem Res. 2008, 124: 35-39. 10.1007/s12011-008-8120-0.View ArticlePubMedGoogle Scholar
- Widomski D, Fretland DJ, Gasiecki AF, Collins PW: The prostaglandin analogs, misoprostol and SC-46275, potently inhibit cytokine release from activated human monocytes. Immunopharmacol Immunotoxicol. 1997, 19: 165-174. 10.3109/08923979709007656.View ArticlePubMedGoogle Scholar
- Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM: Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 1991, 22: 1276-1283. 10.1161/01.STR.22.10.1276.View ArticlePubMedGoogle Scholar
- Hartl R, Schurer L, Schmid-Schonbein GW, Zoppo GJ: Experimental antileukocyte interventions in cerebral ischemia. J Cereb Blood Flow Metab. 1996, 16: 1108-1119.View ArticlePubMedGoogle Scholar
- Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR: Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 1994, 25: 869-875. 10.1161/01.STR.25.4.869.View ArticlePubMedGoogle Scholar
- Guo JY, Huo HR, Yang YX, Li CH, Liu HB, Zhao BS, Li LF, Ma YY, Guo SY, Jiang TL: 2-methoxycinnamaldehyde reduces IL-1beta-induced prostaglandin production in rat cerebral endothelial cells. Biol Pharm Bull. 2006, 29: 2214-2221. 10.1248/bpb.29.2214.View ArticlePubMedGoogle Scholar
- Ugusman A, Zakaria Z, Hui CK, Nordin NA: Piper sarmentosum inhibits ICAM-1 and Nox4 gene expression in oxidative stress-induced human umbilical vein endothelial cells. BMC Complement Altern Med. 2011, 11: 31-10.1186/1472-6882-11-31.View ArticlePubMedPubMed CentralGoogle Scholar
- Berti R, Williams AJ, Moffett JR, Hale SL, Velarde LC, Elliott PJ, Yao C, Dave JR, Tortella FC: Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab. 2002, 22: 1068-1079.View ArticlePubMedGoogle Scholar
- Liu Z, Li P, Zhao D, Tang H, Guo J: Anti-inflammation Effects of Cordyceps sinensis Mycelium in Focal Cerebral Ischemic Injury Rats. Inflammation.
- Mandai M, Yoshimura N, Yoshida M, Iwaki M, Honda Y: The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG-nitro-L-arginine. Invest Ophthalmol Vis Sci. 1994, 35: 3673-3680.PubMedGoogle Scholar
- Endres S, Fülle HJ, Sinha B, Stoll D, Dinarello CA, Gerzer R, Weber PC: Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. Immunology. 1991, 72: 56-60.PubMedPubMed CentralGoogle Scholar
- Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao BS, Luo F: Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol. 2009, 612: 54-60. 10.1016/j.ejphar.2009.03.076.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/11/100/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.